|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0011209,
umls-concept:C0017337,
umls-concept:C0020971,
umls-concept:C0025202,
umls-concept:C0030705,
umls-concept:C0079460,
umls-concept:C0221920,
umls-concept:C0281722,
umls-concept:C0920321,
umls-concept:C1123023,
umls-concept:C1420066
|
|
pubmed:issue |
2 Pt 1
|
|
pubmed:dateCreated |
2007-1-26
|
|
pubmed:abstractText |
We examined in vivo particle-mediated epidermal delivery (PMED) of cDNAs for gp100 and granulocyte macrophage colony-stimulating factor (GM-CSF) into uninvolved skin of melanoma patients. The aims of this phase I study were to assess the safety and immunologic effects of PMED of these genes in melanoma patients.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:AlbertiniMark RMR,
pubmed-author:BridgesAlan JAJ,
pubmed-author:CassadayRyan DRD,
pubmed-author:GanJacekJ,
pubmed-author:HankJacquelyn AJA,
pubmed-author:KimKyung MannKM,
pubmed-author:KingDavid MDM,
pubmed-author:MacklinMichael DMD,
pubmed-author:MahviDavid MDM,
pubmed-author:SchalchHeidi GHG,
pubmed-author:SondelPaul MPM,
pubmed-author:WarnerTom FTF,
pubmed-author:ZulegerCindy LCL
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
540-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17255276-Administration, Cutaneous,
pubmed-meshheading:17255276-Adult,
pubmed-meshheading:17255276-Aged,
pubmed-meshheading:17255276-Autoimmunity,
pubmed-meshheading:17255276-Biopsy,
pubmed-meshheading:17255276-DNA, Complementary,
pubmed-meshheading:17255276-Female,
pubmed-meshheading:17255276-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:17255276-Humans,
pubmed-meshheading:17255276-Male,
pubmed-meshheading:17255276-Melanoma,
pubmed-meshheading:17255276-Membrane Glycoproteins,
pubmed-meshheading:17255276-Middle Aged,
pubmed-meshheading:17255276-Skin,
pubmed-meshheading:17255276-Skin Neoplasms,
pubmed-meshheading:17255276-Vaccines, DNA,
pubmed-meshheading:17255276-gp100 Melanoma Antigen
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients.
|
|
pubmed:affiliation |
Paul P. Carbone Comprehensive Cancer Center, University of Wisconsin, 600 Highland Avenue, Madison, WI 53792, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I,
Research Support, N.I.H., Extramural
|
